Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2010

01.04.2010 | Clinical trial

Effect of air travel on lymphedema risk in women with history of breast cancer

verfasst von: Sharon L. Kilbreath, Leigh C. Ward, Kirstin Lane, Margaret McNeely, Elizabeth S. Dylke, Kathryn M. Refshauge, Don McKenzie, Mi-Joung Lee, Carolyn Peddle, Katie J. Battersby

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

To assess the impact of air travel on swelling of the ‘at risk’ arm of women treated for breast cancer. Women treated for breast cancer from Canada (n = 60) and from within Australia (n = 12) attending a dragon boat regatta in Queensland, Australia participated. Women were measured within 2 weeks prior to their flight, on arrival in Queensland and, for 40 women travelling from Canada, measured again 6 weeks following return to Canada. Changes to extracellular fluid were measured using a single-frequency bioimpedance device (BIA). Each arm was measured separately using a standardized protocol to obtain the inter-limb impedance ratio. An increase in the ratio indicates accumulated fluid. Information regarding medical management of participants’ breast cancer, use of compression garment and history of exercise were also obtained. For most women (95%), air travel did not adversely affect the impedance ratio. The BIA ratio of long-haul travellers was 1.007 ± 0.065 prior to the flight and 1.006 ± 0.087 following the flight. The ratio of short-haul travellers was 0.994 ± 0.033 and following the flight was 1.001 ± 0.038. Air travel did not cause significant change in BIA ratio in the ‘at-risk’ arm for the majority of breast cancer survivors who participated in dragon boat racing. Further research is required to determine whether these findings are generalizable to the population of women who have been treated for breast cancer.
Literatur
1.
Zurück zum Zitat Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM (2007) The development of an arm activity survey for breast cancer survivors using the Protection Motivation Theory. BMC Cancer 7:75CrossRefPubMed Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM (2007) The development of an arm activity survey for breast cancer survivors using the Protection Motivation Theory. BMC Cancer 7:75CrossRefPubMed
2.
Zurück zum Zitat Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM, Harris LM (2009) Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum 36(4):454–462CrossRefPubMed Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM, Harris LM (2009) Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum 36(4):454–462CrossRefPubMed
3.
Zurück zum Zitat Zuther J (2005) Treatment. In: Lymphedema management: the comprehensive guide for practitioners, 2 edn. Thieme Medical Publishers, New York, pp 222–224 Zuther J (2005) Treatment. In: Lymphedema management: the comprehensive guide for practitioners, 2 edn. Thieme Medical Publishers, New York, pp 222–224
4.
Zurück zum Zitat Casley-Smith J, Casley-Smith J (1996) Lymphedema initiated by aircraft flights. Aviat Space Environ Med 67:52–56PubMed Casley-Smith J, Casley-Smith J (1996) Lymphedema initiated by aircraft flights. Aviat Space Environ Med 67:52–56PubMed
5.
Zurück zum Zitat Toff W, Jones C, Ford I, Pearse R, Watson H, Watt S, Ross J, Gradwell D, Batchelor A, Abrams K et al (2006) Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation. JAMA 295(19):2251–2261CrossRefPubMed Toff W, Jones C, Ford I, Pearse R, Watson H, Watt S, Ross J, Gradwell D, Batchelor A, Abrams K et al (2006) Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation. JAMA 295(19):2251–2261CrossRefPubMed
6.
Zurück zum Zitat Ward LC, Battersby KJ, Kilbreath SL (2009) Airplane travel and lymphedema: a case study. Lymphology 42(3):139–145PubMed Ward LC, Battersby KJ, Kilbreath SL (2009) Airplane travel and lymphedema: a case study. Lymphology 42(3):139–145PubMed
7.
Zurück zum Zitat Graham PH (2002) Compression prophylaxis may increase the potential for flight-associated lymphoedema after breast cancer treatment. Breast 11:66–71CrossRefPubMed Graham PH (2002) Compression prophylaxis may increase the potential for flight-associated lymphoedema after breast cancer treatment. Breast 11:66–71CrossRefPubMed
8.
Zurück zum Zitat Cornish BH, Bunce IH, Ward LC, Jones LC, Thomas BJ (1996) Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes. Breast Cancer Res Treat 38(2):169–176CrossRefPubMed Cornish BH, Bunce IH, Ward LC, Jones LC, Thomas BJ (1996) Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes. Breast Cancer Res Treat 38(2):169–176CrossRefPubMed
9.
Zurück zum Zitat Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ (2001) Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34(1):2–11PubMed Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ (2001) Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34(1):2–11PubMed
10.
Zurück zum Zitat Czerniec S, Kilbreath S, Ward L, Refshauge K, Beith J, Lee M, York S (2010) Assessment of breast cancer related arm lymphoedema—comparison of physical measurement methods and self-report. Cancer Invest 28(1):54–62CrossRefPubMed Czerniec S, Kilbreath S, Ward L, Refshauge K, Beith J, Lee M, York S (2010) Assessment of breast cancer related arm lymphoedema—comparison of physical measurement methods and self-report. Cancer Invest 28(1):54–62CrossRefPubMed
11.
Zurück zum Zitat Ward LC, Kilbreath S, Cornish BH (2008) Bioimpedance analysis for early detection of lymphedema. In: Weissieder H, Schuchhardt C (eds) Lymphedema: diagnosis and therapy, 4th edn. Viavital Verlag, Essen, pp 502–517 Ward LC, Kilbreath S, Cornish BH (2008) Bioimpedance analysis for early detection of lymphedema. In: Weissieder H, Schuchhardt C (eds) Lymphedema: diagnosis and therapy, 4th edn. Viavital Verlag, Essen, pp 502–517
12.
Zurück zum Zitat Ahmed RL, Thomas W, Yee D, Schmitz KH (2006) Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 24:2765–2772CrossRefPubMed Ahmed RL, Thomas W, Yee D, Schmitz KH (2006) Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 24:2765–2772CrossRefPubMed
13.
Zurück zum Zitat Lane K, Jespersen D, McKenzie DC (2005) The effect of a whole body exercise programme and dragon boat training on arm volume and arm circumference in women treated for breast cancer. Eur J Cancer Care 14(4):353–358CrossRef Lane K, Jespersen D, McKenzie DC (2005) The effect of a whole body exercise programme and dragon boat training on arm volume and arm circumference in women treated for breast cancer. Eur J Cancer Care 14(4):353–358CrossRef
14.
Zurück zum Zitat Brennan MJ (1992) Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage 7(2):110–116CrossRefPubMed Brennan MJ (1992) Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage 7(2):110–116CrossRefPubMed
16.
Zurück zum Zitat Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361(7):664–673CrossRefPubMed Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361(7):664–673CrossRefPubMed
17.
Zurück zum Zitat McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213–5219CrossRefPubMed McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213–5219CrossRefPubMed
Metadaten
Titel
Effect of air travel on lymphedema risk in women with history of breast cancer
verfasst von
Sharon L. Kilbreath
Leigh C. Ward
Kirstin Lane
Margaret McNeely
Elizabeth S. Dylke
Kathryn M. Refshauge
Don McKenzie
Mi-Joung Lee
Carolyn Peddle
Katie J. Battersby
Publikationsdatum
01.04.2010
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2010
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0793-3

Weitere Artikel der Ausgabe 3/2010

Breast Cancer Research and Treatment 3/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.